Publications by authors named "Lyle Fried"

Claim this Profile
H
Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.
Lyle Fried, Edward J Modestino, David Siwicki, Lisa Lott, Panayotis K Thanos

Curr Pharm Biotechnol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.
Kenneth Blum, David Baron, Lisa Lott, Jessica V Ponce, David Siwicki, Lyle Fried

Curr Psychopharmacol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Death by Opioids: Are there non-addictive scientific solutions?
B William Downs, Kenneth Blum, David Baron, Abdalla Bowirrat, Lisa Lott, Lyle Fried

J Syst Integr Neurosci· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
Blum Kenneth, Modestino J Edward, Gondre Lewis C Marjorie, Baron David, Steinberg Bruce, Fried Lyle

CPQ Neurol Psychol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Addiction Risk Score (GARS) as a Predictor of Substance Use Disorder: Identifying Predisposition Not Diagnosis.
Kenneth Blum, Lisa Lott, David Siwicki, Lyle Fried, Mary Hauser

Curr Trends Med Diagn Methods· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD.
Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, Edward J Modestino, Lyle Fried

J Behav Addict· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Benefits of Genetic Addiction Risk Score (GARS) Testing in Substance Use Disorder (SUD).
Kenneth Blum, Edward J Modestino, Marjorie Gondre-Lewis, Edwin J Chapman, Jennifer Neary, Lyle Fried

Int J Genom Data Min· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.
Kenneth Blum, Amanda L C Chen, Panayotis K Thanos, Marcelo Febo, Zsolt Demetrovics, Lyle Fried

Front Biosci (Elite Ed)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic.
Kenneth Blum, Edward J Modestino, Marjorie Gondré-Lewis, B William Downs, David Baron, Lyle Fried

J Syst Integr Neurosci· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of residential dual diagnosis treatment on alcohol abuse.
Stephen J Schoenthaler, Kenneth Blum, Lyle Fried, Marlene Oscar-Berman, John Giordano

J Syst Integr Neurosci· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission.
Kenneth Blum, Edward J Modestino, Marcelo Febo, Bruce Steinberg, Thomas McLaughlin, Lyle Fried

J Syst Integr Neurosci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone?
Thomas McLaughlin, David Han, James Nicholson, Bruce Steinberg, Kenneth Blum, Lyle Fried

J Syst Integr Neurosci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS).
Kenneth Blum, Marcelo Febo, Lyle Fried, David Baron, Eric R Braverman

J Reward Defic Syndr Addict Sci· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical Analysis of White House Anti-Drug Plan.
Kenneth Blum, Lyle Fried, Margaret A Madigan, John Giordano, Edward J Modestino

Glob J Addict Rehabil Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Kenneth Blum, Marcelo Febo, Lyle Fried, Mona Li, Kristina Dushaj

Subst Use Misuse· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD).
Kenneth Blum, Margaret A Madigan, Lyle Fried, Eric R Braverman, John Giordano

Glob J Addict Rehabil Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS.
Kenneth Blum, B W Downs, Kristina Dushaj, Mona Li, Eric R Braverman, Lyle Fried

Precis Med (Bangalore)· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis